163 related articles for article (PubMed ID: 23358800)
1. Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas.
Cao WD; Kawai N; Miyake K; Zhang X; Fei Z; Tamiya T
Brain Tumor Pathol; 2014 Jan; 31(1):1-10. PubMed ID: 23358800
[TBL] [Abstract][Full Text] [Related]
2. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
Jensen RL; Ragel BT; Whang K; Gillespie D
J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.
Korkolopoulou P; Patsouris E; Konstantinidou AE; Pavlopoulos PM; Kavantzas N; Boviatsis E; Thymara I; Perdiki M; Thomas-Tsagli E; Angelidakis D; Rologis D; Sakkas D
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):267-78. PubMed ID: 15175080
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
7. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
9. The expression and significance of HIF-1alpha and GLUT-3 in glioma.
Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X
Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666
[TBL] [Abstract][Full Text] [Related]
10. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
[TBL] [Abstract][Full Text] [Related]
11. AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.
Mou K; Chen M; Mao Q; Wang P; Ni R; Xia X; Liu Y
J Neurooncol; 2010 Dec; 100(3):375-83. PubMed ID: 20467785
[TBL] [Abstract][Full Text] [Related]
12. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
13. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
Kuijper A; van der Groep P; van der Wall E; van Diest PJ
Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
17. [Expression of hypoxia-inducible factor-1alpha in nasal polyps and its correlation with vascular endothelial growth factor and inducible nitric oxide synthase].
Liu Y; Cui YH; Yu LL; Liu Z; Zhang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 May; 40(5):366-70. PubMed ID: 16229182
[TBL] [Abstract][Full Text] [Related]
18. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between the expression of HIF-1alpha and the angiogenesis in infancy hemangioma].
Chen D; Lin XX; Li W
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Mar; 21(2):115-8. PubMed ID: 16011198
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]